top of page
Proteomics~Diagnostics~Clinical
Consulting
We are standing at the threshold of enormous advancements in biotechnology, and I am fortunate to be a participant in this transformational time. Beginning with my research and fellowship appointments at MIT and Harvard, I have worked as a Scientist, Director and then Executive inside this rapidly evolving industry.
When I look toward the future, I see an industry that continues to develop better diagnostics for early detection, treatability and survival for diseases such as diabetes and cancer. I am driven to see the successful development of companion diagnostics, for example, and honored to have been invited to present at countless scientific conferences and co-author more than 70 relevant papers.
​
​
bottom of page